Literature DB >> 32965743

Reducing aerosol transmission of SARS-CoV-2 in hospital elevators.

Cees van Rijn1, G Aernout Somsen2, Leonard Hofstra2,3, Ghassan Dahhan1, Reinout A Bem3, Stefan Kooij1, Daniel Bonn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32965743      PMCID: PMC7537012          DOI: 10.1111/ina.12744

Source DB:  PubMed          Journal:  Indoor Air        ISSN: 0905-6947            Impact factor:   5.770


× No keyword cloud information.
There is a worldwide discussion on the role of aerosols in the transmission of SARS‐CoV‐2. The WHO has recently highlighted the possible role of aerosols in the transmission of SARS‐CoV‐2. Aerosols containing small respirable particles are increasingly recognized as a potentially important mode of transmission of SARS‐CoV‐2. , , , We investigate aerosol droplet persistence inside the confined space of hospital elevators and propose specific measures to reduce the associated risk of SARS‐CoV‐2 transmission. To investigate aerosol persistence in elevators, we mimic a single cough using a specially designed spray nozzle to disperse a controlled quantity of glycerol/ethanol droplets, that after evaporation of the ethanol have the same size distribution as evaporated respiratory droplets from a single cough. A SprayScan® laser sheet is used to detect aerosols that were placed in the back of the elevator at half‐height. Experiments were performed inside elevator cabins during normal operation with about 10%‐20% open door time. We found that it typically takes 12‐18 minutes before the number of aerosol particles decreased 100‐fold during normal operation of both medium‐ and large‐sized elevator cabins. With elevator doors permanently open, this time is reduced to 2‐4 minutes (Figure 1). In all cases, the number of aerosols decreases exponentially in time.
Figure 1

Aerosol droplets in elevators. Averaged number of aerosol droplets as a function of time since production as counted in large (15‐20 m3) elevator cabins [triangles] and medium‐sized (8‐12 m3) cabins [diamonds] during normal operation [orange], with permanently open doors [green], and permanently closed [red]. In all experiments, the ventilation was on with an average ACH = 10 value

Aerosol droplets in elevators. Averaged number of aerosol droplets as a function of time since production as counted in large (15‐20 m3) elevator cabins [triangles] and medium‐sized (8‐12 m3) cabins [diamonds] during normal operation [orange], with permanently open doors [green], and permanently closed [red]. In all experiments, the ventilation was on with an average ACH = 10 value SARS‐CoV‐2‐infected sputum droplets from hospitalized but generally mildly ill people may carry between 104 and 109 RNA copies per mL. A value of 109 implies roughly one virus particle per aerosol droplet with a radius of 5 µm; loud speaking may produce up to a few hundred thousand droplets per minute, , , whereas a single cough can already produce a few million droplets. Breathing the air after speaking or coughing of an infected patient inside an elevator with a volume of 10‐15 m3 and inhaling about 8 L/min then implies a potential intake of tens up to many thousands SARS‐CoV‐2 RNA copies per minute, depending on the patient's infectivity. The minimum infectious dose for SARS‐CoV‐2 has not been reported; the severity of COVID‐19 is, however, believed to be proportional to the dose of the initial inoculum, implying that transmission by aerosols may lead to relatively milder symptoms. Specific measures to reduce the risk of SARS‐CoV‐2 transmission may include leaving elevator doors open for a longer period, as is suggested by our data (Figure 1) on open doors. Also wearing an adequate face mask might possibly reduce this risk. A medical grade face mask comprising an electret layer (eg, N95 or N99) to capture aerosols with an efficacy of more than 95% is a good measure for more protection in the confined space of an elevator. An increase of the elevator's mechanical ventilation capacity is also recommended. Current standards for the air change rate by mechanical ventilation in hospital elevators may vary between 6 and 20 air changes per hour. If we assume that aerosol particles will be continuously mixed with supply air, without taking into account particle deposition, re‐suspension, and stagnant flows, an air change rate of 10 times per hour implies a 100‐fold reduction in aerosol particles in about 28 minutes. From the experiments, we find a 100‐fold reduction in 24‐30 minutes (cf. ACH = 10) with closed doors, 12‐18 minutes during operation, and 3‐5 minutes with open doors (Figure 1). A remarkable finding was that the ventilation inside all studied elevators in idle position automatically shuts off after 1‐2 minutes, which of course can easily be prolonged by reprogramming the action control software. In most hospital elevators, the ventilator is present in the ceiling and exhausts air from the cabin toward the elevator shaft. A possible measure is reversing the flow direction of the ventilator, herewith creating a unidirectional downflow of fresh (eg, HEPA filtered) air from the ceiling towards the floor of the elevator cabin, a measure that is standard in most operating rooms to create and maintain an airborne microbial free environment.

CONFLICT OF INTEREST

None reported.

AUTHOR CONTRIBUTION

Cees van Rijn: Conceptualization (equal); Data curation (equal); Investigation (equal). G. Aernout Somsen: Conceptualization (equal); Investigation (equal). Leonard Hofstra: Conceptualization (equal); Data curation (equal). Ghassan Dahhan: Conceptualization (equal). Reinout A. Bem: Conceptualization (equal); Methodology (equal). Stefan Kooij: Data curation (equal); Investigation (equal). Daniel Bonn: Conceptualization (equal); Data curation (equal); Investigation (equal); Methodology (equal); Project administration (equal); Writing‐original draft (equal); Writing‐review & editing (equal).

Funding information

SARS‐CoV‐2 University of Amsterdam fund.

Peer Review

The peer review history for this article is available at https://publons.com/publon/10.1111/ina.12744.
  6 in total

1.  On airborne virus transmission in elevators and confined spaces.

Authors:  Talib Dbouk; Dimitris Drikakis
Journal:  Phys Fluids (1994)       Date:  2021-01-26       Impact factor: 3.521

2.  Risk of aerosol transmission of SARS-CoV-2 in a clinical cardiology setting.

Authors:  G Aernout Somsen; Michiel M Winter; Igor I Tulevski; Stefan Kooij; Daniel Bonn
Journal:  Build Environ       Date:  2022-06-11       Impact factor: 7.093

3.  Silica-encapsulated DNA tracers for measuring aerosol distribution dynamics in real-world settings.

Authors:  Anne M Luescher; Julian Koch; Wendelin J Stark; Robert N Grass
Journal:  Indoor Air       Date:  2021-10-21       Impact factor: 6.554

4.  Measurement of small droplet aerosol concentrations in public spaces using handheld particle counters.

Authors:  G Aernout Somsen; Cees J M van Rijn; Stefan Kooij; Reinout A Bem; Daniel Bonn
Journal:  Phys Fluids (1994)       Date:  2020-12-01       Impact factor: 3.521

5.  Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand.

Authors:  Jordan Douglas; Jemma L Geoghegan; James Hadfield; Remco Bouckaert; Matthew Storey; Xiaoyun Ren; Joep de Ligt; Nigel French; David Welch
Journal:  Emerg Infect Dis       Date:  2021-09       Impact factor: 6.883

6.  Elevator Cabin Decontamination With ACTIVE Particle Control™ Technology.

Authors:  Mark Ereth; Tracy Wagoner; Mark Blevins; Donald Hess
Journal:  Front Public Health       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.